The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction, diabetes and kidney function

被引：4
|
作者：
Voordes, Geert H. D. [1 ]
Heerspink, Hiddo J. L. [2 ]
ter Maaten, Jozine M. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷 / 05期
关键词：
LCZ696;
D O I：
10.1002/ejhf.2501
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：804 / 806
页数：3
相关论文
共 50 条
  • [31] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [32] Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
    Solomon, Scott D.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Pfeffer, Marc A.
    Desai, Akshay
    Lund, Lars H.
    Kober, Lars
    Anand, Inder
    Sweitzer, Nancy
    Linssen, Gerard
    Merkely, Bela
    Arango, Juan Luis
    Vinereanu, Dragos
    Chen, Chen-Huan
    Senni, Michele
    Sibulo, Antonio
    Boytsov, Sergey
    Shi, Victor
    Rizkala, Adel
    Lefkowitz, Martin
    McMurray, John J., V
    CIRCULATION, 2020, 141 (05) : 352 - 361
  • [33] DIASTOLIC FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED BY SACUBITRIL/VALSARTAN
    Lamaida, N.
    Cerciello, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [34] Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
    Edmonston, Daniel
    Sparks, Matthew
    Rajagopal, Sudarshan
    Wolf, Myles
    KIDNEY360, 2023, 4 (05): : 631 - 640
  • [35] EFFECTS OF SACUBITRIL-VALSARTAN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Fu, Sha
    Xu, Zhenjian
    Lin, Baojuan
    Chen, Junzhe
    Huang, Qiuyan
    Xu, Yanchun
    Xu, Anping
    Chen, Yangxin
    Tang, Ying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1558 - 1558
  • [36] Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
    Basile, Christian
    Paolillo, Stefania
    Gargiulo, Paola
    Marzano, Federica
    Asile, Gaetano
    Parlati, Antonio Luca Maria
    Chirico, Alfonsina
    Nardi, Ermanno
    Buonocore, Davide
    Colella, Angela
    Perrone-Filardi, Pasquale
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (01) : 44 - 51
  • [37] Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
    Fu, Sha
    Xu, Zhenjian
    Lin, Baojuan
    Chen, Junzhe
    Huang, Qiuyan
    Xu, Yanchun
    Xu, Anping
    Chen, Yangxin
    Tang, Ying
    FRONTIERS IN MEDICINE, 2021, 8
  • [38] Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction
    Shi, Yu Jiao
    Yang, Chen Guang
    Qiao, Wen Bo
    Liu, Yong Cheng
    Liu, Si Yu
    Dong, Guo Ju
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [39] Study on the efficacy of sacubitril/valsartan in patients with heart failure with preserved ejection fraction undergoing peritoneal dialysis
    Sheng, Yuping
    Ma, Xiaoying
    Liu, Ye
    Yang, Xingmeng
    Sun, Fuyun
    CARDIOLOGY, 2023, 148 (05) : 385 - 394
  • [40] Renin-angiotensin-aldosterone fingerprint in treatment of heart failure with preserved ejection fraction with sacubitril/valsartan
    Dachs, T.
    Nagele, F.
    Rettl, R.
    Poglitsch, M.
    Dalos, D.
    Duca, F.
    Binder-Rodriguez, C.
    Camuz-Ligios, L.
    Dusik, F.
    Seirer, B.
    Hengstenberg, C.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S207 - S207
12345